CTNNB1 and neoplasm: Importantly, murine studies have demonstrated that mutations in CTNNB1 are tumour drivers and provided important insights into the role of the nucleocytoplasmic β-catenin cell clusters in ACP tumourigenesis (see below) [43, 75].